Literature DB >> 20852318

Stereotactic low-voltage x-ray irradiation for age-related macular degeneration.

Darius M Moshfeghi1, Peter K Kaiser, Michael Gertner.   

Abstract

The IRay stereotactic low-voltage x-ray irradiation treatment system for age-related macular degeneration consists of a low voltage x-ray tube, an eye tracking system, a robotically controlled delivery system, a coupling device to facilitate tracking and stabilisation, a graphical user interface and gating software. Low-voltage x-rays are delivered in a series of three spots to the macula in a non-invasive manner through the inferior pars plana. These beams are designed to overlap on the centre of the macula. Each beam delivers one-third of the total dose, such that the total macula dose is three times an individual beam's dose. The device is designed to run off standard domestic electrical power, and no special shielding is necessary for the room. This system has been validated in Monte Carlo simulations, human cadaver eye studies, pre-clinical animal studies and in a phase I clinical trial.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20852318     DOI: 10.1136/bjo.2009.163907

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  [In Process Citation].

Authors: 
Journal:  Ophthalmologe       Date:  2015-11       Impact factor: 1.059

2.  Epimacular brachytherapy - old ghost or new age?

Authors:  Norbert Bornfeld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-02-20       Impact factor: 3.117

Review 3.  [Adjuvant radiotherapy during anti-VEGF in neovascular age-related macular degeneration].

Authors:  P Rating; M-A Freimuth; M Stuschke; N Bornfeld
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

4.  [Adjuvant stereotactic low energy radiation therapy of exudative age-dependent macular degeneration (Oraya system)].

Authors:  S Pollithy; N Celik; H Höh; S Dithmar
Journal:  Ophthalmologe       Date:  2013-05       Impact factor: 1.059

Review 5.  Targeted radiotherapy with gold nanoparticles: current status and future perspectives.

Authors:  Wilfred Ngwa; Rajiv Kumar; Srinivas Sridhar; Houari Korideck; Piotr Zygmanski; Robert A Cormack; Ross Berbeco; G Mike Makrigiorgos
Journal:  Nanomedicine (Lond)       Date:  2014-05       Impact factor: 5.307

6.  Radiation therapy for neovascular age-related macular degeneration.

Authors:  Robert Petrarca; Timothy L Jackson
Journal:  Clin Ophthalmol       Date:  2011-01-10

Review 7.  Therapies for neovascular age-related macular degeneration: current approaches and pharmacologic agents in development.

Authors:  Mostafa Hanout; Daniel Ferraz; Mehreen Ansari; Natasha Maqsood; Saleema Kherani; Yasir J Sepah; Nithya Rajagopalan; Mohamed Ibrahim; Diana V Do; Quan Dong Nguyen
Journal:  Biomed Res Int       Date:  2013-11-11       Impact factor: 3.411

8.  StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): study protocol for a randomised controlled clinical trial.

Authors:  James E Neffendorf; Riti Desai; Yanzhong Wang; Joanna Kelly; Caroline Murphy; Barnaby C Reeves; Usha Chakravarthy; Sarah Wordsworth; Cornelius Lewis; Janet Peacock; Shahir Uddin; Joe M O'Sullivan; Timothy L Jackson
Journal:  Trials       Date:  2016-11-24       Impact factor: 2.279

9.  IRay therapy as an adjuvant therapy in newly diagnosed patients with neovascular age-related macular degeneration.

Authors:  Christopher Brand; Mark Arnoldussen
Journal:  Eye (Lond)       Date:  2018-04-17       Impact factor: 3.775

Review 10.  Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives.

Authors:  James E Neffendorf; Timothy L Jackson
Journal:  Clin Ophthalmol       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.